Novartis Investigative Site

Yamagata, Yamagata 990-9585

0 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, Leukemia, Myelomonocytic, Chronic, Lymphangioleiomyomatosis (LAM), Metastatic Renal Cell Carcinoma, Myelodysplastic Syndromes, Pulmonary Disease, Chronic Obstructive, Tuberous Sclerosis Complex (TSC)

Studies at this site

• A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy — Stopped early
• Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2) — Stopped early
• Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients — Completed
• Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) — Completed
• Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma — Completed